HSPB1 and Parkinson disease: Methods: We used human iPSC-derived dopaminergic neurons and Coniferaldehyde (CFA)—an Nrf2 agonist known for its ability to cross the blood-brain barrier—to investigate the role of Hspb1 in PD.